You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Optimizing the therapeutic activity of sphingosine-1-phosphate receptor modulators through lymph targeted delivery
- In: Posters G - Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PG-034
- By: CAO, Enyuan (Monash University, Pharmaceutics, Parkville, Australia)
- Co-author(s): Trevaskis, Natalie (Monash University, Parkville, Australia)
Hu, Luojuan (Monash University, Parkville, Australia)
Christopolous, George (Monash University, Parkville, Australia)
Aurelio, Luigi (Monash University, Parkville, Australia)
Sexton, Patrick (Monash University, Parkville, Australia)
Flynn, Bernard (Monash University, Parkville, Australia)
Porter, Christopher (Monash University, Parkville, Australia) - Abstract:
Background: Sphingosine-1-phosphate (S1P) receptor modulators (S1PRMs) show therapeutic effect in autoimmune disease by blocking lymphocyte egress from lymph nodes resulting in systemic lymphopenia. The S1PRM fingolimod is used clinically for multiple sclerosis but has significant off-target toxicities. Targeting S1PRM to their site of action..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026